Teva Pharmaceutical Industries, the international drug maker linked to the 2008 hepatitis C outbreak in Las Vegas, has agreed to buy Allergan Plc's generic drugs business for $40.5 billion in a cash and stock deal that will turn the Israeli company into one of the world's largest pharmaceutical firms.
Source Business http://ift.tt/1JM8miw
ليست هناك تعليقات:
إرسال تعليق